Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika M Moore

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Annals of Biomedical Engineering|December 12, 2018
Harnessing Macrophages for Vascularization in Tissue EngineeringErika M Moore, Jennifer L West
American Journal of Clinical Pathology|December 17, 2024
How I diagnose high-grade B-cell lymphomaErika M Moore, Sarah E Gibson
Blood|January 17, 2017
Plasma cell leukemia mimicking acute myeloid leukemiaErika M Moore, Christine G Roth
Human Pathology|August 26, 2023
The clinical significance of increased large cells in marginal zone lymphomaTravis Stueber, Vanya Jaitly, Erika M Moore
American Journal of Clinical Pathology|April 20, 2021
Pathogenic Mutations and Atypical Flow Cytometric Findings Characterize the Majority of Unclassifiable Myelodysplastic/Myeloproliferative NeoplasmsYanchun Li, Rose C Beck, Erika M Moore
Human Pathology|April 26, 2022
Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphomaChristopher B Ryder, Kwadwo A Oduro, Erika M Moore
Human Pathology|August 31, 2017
J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphomaErika M Moore, Steven H Swerdlow, Sarah E Gibson
The American Journal of Surgical Pathology|January 9, 2018
Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin LymphomasErika M Moore, Steven H Swerdlow, Sarah E Gibson
The American Journal of Surgical Pathology|June 15, 2017
Further Exploration of the Complexities of Large B-Cell Lymphomas With MYC Abnormalities and the Importance of a Blastoid MorphologyErika M Moore, Nidhi Aggarwal, Urvashi Surti, et al.
British Journal of Haematology|January 18, 2020
Erythroblastic sarcoma with rare PDGFRA rearrangement responding to tyrosine kinase inhibitor therapyBenjamin Tomlinson, Philipp W Raess, Rose C Beck, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Annals of Biomedical Engineering|December 12, 2018
Harnessing Macrophages for Vascularization in Tissue EngineeringErika M Moore, Jennifer L West
American Journal of Clinical Pathology|December 17, 2024
How I diagnose high-grade B-cell lymphomaErika M Moore, Sarah E Gibson
Blood|January 17, 2017
Plasma cell leukemia mimicking acute myeloid leukemiaErika M Moore, Christine G Roth
Human Pathology|August 26, 2023
The clinical significance of increased large cells in marginal zone lymphomaTravis Stueber, Vanya Jaitly, Erika M Moore
American Journal of Clinical Pathology|April 20, 2021
Pathogenic Mutations and Atypical Flow Cytometric Findings Characterize the Majority of Unclassifiable Myelodysplastic/Myeloproliferative NeoplasmsYanchun Li, Rose C Beck, Erika M Moore
Human Pathology|April 26, 2022
Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphomaChristopher B Ryder, Kwadwo A Oduro, Erika M Moore
Human Pathology|August 31, 2017
J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphomaErika M Moore, Steven H Swerdlow, Sarah E Gibson
The American Journal of Surgical Pathology|January 9, 2018
Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin LymphomasErika M Moore, Steven H Swerdlow, Sarah E Gibson
The American Journal of Surgical Pathology|June 15, 2017
Further Exploration of the Complexities of Large B-Cell Lymphomas With MYC Abnormalities and the Importance of a Blastoid MorphologyErika M Moore, Nidhi Aggarwal, Urvashi Surti, et al.
British Journal of Haematology|January 18, 2020
Erythroblastic sarcoma with rare PDGFRA rearrangement responding to tyrosine kinase inhibitor therapyBenjamin Tomlinson, Philipp W Raess, Rose C Beck, et al.
Pageof 4